Bharat B Yarlagadda1, Daniel G Deschler1, Debbie L Rich2, Derrick T Lin1, Kevin S Emerick1, James W Rocco1, Marlene L Durand3,4. 1. Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts. 2. Department of Nursing, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts. 3. Infectious Disease Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts. 4. Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Abstract
BACKGROUND: Compliance with Surgical Care Improvement Project (SCIP) parameters regarding antibiotic prophylaxis may affect surgical site infection rates. The purpose of this study was for us to report SCIP compliance, surgical site infection rates, and risk factors in a large series of head and neck free flap surgeries. METHODS: A retrospective review of 480 free flap cases was performed. Surgical site infections occurring within 30 days postoperatively were noted. RESULTS: Surgical site infection occurred in 13.3% of cases. Prophylaxis was given in 99.8% of cases; ampicillin-sulbactam (83%) and clindamycin (9%) were most common. Prophylaxis was "on-time" in 92.3% of cases. There were no significant associations between surgical site infection and tumor stage, American Society of Anesthesiologists (ASA) classification, tumor subsite, or flap type. Prior radiation was a risk factor for surgical site infection in patients treated for malignancy. CONCLUSION: A surgical site infection rate of 13.3% was noted. In this cohort, with a compliance rate with prophylactic antibiotic measures, prior radiation was found to be a risk factor only in patients with cancer.
BACKGROUND: Compliance with Surgical Care Improvement Project (SCIP) parameters regarding antibiotic prophylaxis may affect surgical site infection rates. The purpose of this study was for us to report SCIP compliance, surgical site infection rates, and risk factors in a large series of head and neck free flap surgeries. METHODS: A retrospective review of 480 free flap cases was performed. Surgical site infections occurring within 30 days postoperatively were noted. RESULTS: Surgical site infection occurred in 13.3% of cases. Prophylaxis was given in 99.8% of cases; ampicillin-sulbactam (83%) and clindamycin (9%) were most common. Prophylaxis was "on-time" in 92.3% of cases. There were no significant associations between surgical site infection and tumor stage, American Society of Anesthesiologists (ASA) classification, tumor subsite, or flap type. Prior radiation was a risk factor for surgical site infection in patients treated for malignancy. CONCLUSION: A surgical site infection rate of 13.3% was noted. In this cohort, with a compliance rate with prophylactic antibiotic measures, prior radiation was found to be a risk factor only in patients with cancer.
Authors: Ahmed Sam Beydoun; Kevin Koss; Tyson Nielsen; Andrew James Holcomb; Priscilla Pichardo; Nicholas Purdy; Aaron L Zebolsky; Chase M Heaton; Caitlin P McMullen; Jessica A Yesensky; Michael G Moore; Neerav Goyal; Joshua Kohan; Mirabelle Sajisevi; Kenneth Tan; Daniel Petrisor; Mark K Wax; Alexandra E Kejner; Zain Hassan; Skylar Trott; Andrew Larson; Jeremy D Richmon; Evan M Graboyes; C Burton Wood; Ryan S Jackson; Patrik Pipkorn; Jennifer Bruening; Becky Massey; Sidharth V Puram; Joseph Zenga Journal: JAMA Otolaryngol Head Neck Surg Date: 2022-06-01 Impact factor: 8.961
Authors: Ashley C Mays; Bharat Yarlagadda; Virginie Achim; Ryan Jackson; Patrik Pipkorn; Andrew T Huang; Karthik Rajasekaran; Shaum Sridharan; Andrew J Rosko; Ryan K Orosco; Andrew M Coughlin; Mark K Wax; Yelizaveta Shnayder; William C Spanos; Donald Gregory Farwell; Lee S McDaniel; Matthew M Hanasono Journal: Head Neck Date: 2021-01-08 Impact factor: 3.147
Authors: Michael M Lindeborg; Rosh K V Sethi; Sidharth V Puram; Anuraag Parikh; Bharat Yarlagadda; Mark Varvares; Kevin Emerick; Derrick Lin; Marlene L Durand; Daniel G Deschler Journal: Laryngoscope Investig Otolaryngol Date: 2020-05-28